UNC and UNC Lineberger researchers and trainees will be presenting talks and participating in scientific and educational panels and discussions on the latest cancer research at the American Society of Clinical Oncology’s Annual Meeting in Chicago, May 31-June 4.
The largest clinical cancer research meeting in the world, ASCO attracts more than 40,000 attendees from around the world. This year’s meeting will feature more than 5,000 scientific abstracts.
The UNC Lineberger presentations include:
Friday, May 31
Rapid Oral Abstract Session
Breast Cancer—Local/Regional/Adjuvant
2:45 – 4:15 p.m. CT | E451
3:39 – 3:45 p.m.: Recurrence score gene axes scores and outcomes by race and ethnicity in the RxPONDER trial. (Abstract: 515)
Yara Abdou, MD
Oral Abstract Session
Care Delivery and Quality Care
2:45 – 5:45 p.m. CT | S100A
4:45 – 4:57 p.m. CT: Implementing financial toxicity and health-related social risks screening and referral. (Abstract: 11006)
Bridgette Thom, PhD
Saturday, June 1
Poster Session
Developmental Therapeutics—Immunotherapy
9 a.m. – 12 p.m. CT | Hall A
A phase 1, first-in-human study of autologous monocytes engineered to express an anti-HER2 chimeric antigen receptor (CAR) in participants with HER2-overexpressing solid tumors. (Abstract: TPS2682 | Poster: 154b)
Yara Abdou, MD
Targeting a non-canonical STING signaling pathway in T cells to improve antitumor immunity. (Abstract: 2574 | Poster: 53)
Jeremy Meier, MD, PhD
Sunday, June 2
Poster Session
Head and Neck Cancer
9 a.m. – 12 p.m. CT | Hall A
Early signs of efficacy in patients with anti-PD-1 naïve and anti-PD-1 resistant HNSCC treated with NBTXR3/SBRT in combination with nivolumab or pembrolizumab in the phase I trial Study 1100. (Abstract: 6035 | Poster: 338)
Colette Shen, MD, PhD
Monday, June 3
Poster Session
Quality Care/Health Services Research
9 a.m. – 12 p.m. CT | Hall A
Association of frailty assessed by a ten-item frailty index (FI-CGA-10) with health-related quality of life in older adults with cancer. (Abstract: 11047 | Poster: 242)
Hyman Muss, MD, FASCO
Implementation and preliminary efficacy of a risk stratification system +/- patient-reported outcomes monitoring for patients with hospital-diagnosed advanced lung cancer. (Abstract: 11095 Poster: 290)
Emily Ray, MD, MPH
Clinical Science Symposium
Use of MRD-Guided Strategies to Optimize Therapeutic Interventions
9:45 – 11:15 a.m. CT | Hall D1
Patient Perspectives
9:57 a.m. CT: Patricia Spears, FASCO
Panel Discussion
11:01 – 11:15 a.m. CT
Discussant: Patricia Spears, FASCO
Oral Abstracts Session
Pediatric Oncology II
11:30 a.m. – 2:30 p.m. CT | S504
1:06 – 1:18 p.m. CT: Sequencing: This Is What You Came For
Discussant: Adam Palmer, PhD
Panel Discussion
Publication 101 – Peer Review & Becoming a Successful Author
12 – 12:45 p.m. CT | Hall C
Panelist: Yara Abdou, MD
Poster Session
Lung Cancer—Non-Small Cell Metastatic
1:30 – 4:30 p.m. CT | Hall A
Efficacy of immunotherapy retreatment in patients with non-small cell lung cancer receiving consolidative durvalumab. (Abstract: 8625 | Poster: 489)
Allison Carroll, PharmD
Oral Abstracts Session
Breast Cancer—Local/Regional/Adjuvant
3 – 6 p.m. CT | Hall B1
4:36 p.m. CT: Treatment and Outcomes in Select Subpopulations With Breast Cancer
Discussant: Lisa A. Carey, MD, ScM, FASCO